Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
EULAR 2012: Does Arthritis Start in the Gut?
New research on the ties between bacteria and inflammatory disease.
Educational Leader Honored with Top Rheumatology Award
Paul Emery, MA, MD, receives prestigious Nachman Prize.
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.